Wessels, A. M. A., Elzinga, F. A., Koppelman, G. H., Akkerman, O. W., Mian, P., & Touw, D. J. (2025). Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1258, 124604. https://doi.org/10.1016/j.jchromb.2025.124604
Chicago-Zitierstil (17. Ausg.)Wessels, A. Mireille A., Femke A. Elzinga, Gerard H. Koppelman, Onno W. Akkerman, Paola Mian, und Daan J. Touw. "Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and Their Active Metabolites in Plasma Using UHPLC-MS/MS: Doors Open to the Application of Therapeutic Drug Monitoring in Cystic Fibrosis Treatment." Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1258 (2025): 124604. https://doi.org/10.1016/j.jchromb.2025.124604.
MLA-Zitierstil (9. Ausg.)Wessels, A. Mireille A., et al. "Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and Their Active Metabolites in Plasma Using UHPLC-MS/MS: Doors Open to the Application of Therapeutic Drug Monitoring in Cystic Fibrosis Treatment." Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, vol. 1258, 2025, p. 124604, https://doi.org/10.1016/j.jchromb.2025.124604.